|
Aug 29
|
Bausch + Lomb Will Participate at the 2023 Wells Fargo Healthcare Conference
|
|
Jun 30
|
Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)
|
|
Jun 30
|
Bausch + Lomb’s CEO Inks First Big Deal Since Return
|
|
Jun 30
|
Bausch + Lomb Will Acquire XIIDRA®
|
|
Apr 26
|
Bausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at the American Society of Cataract and Refractive Surgery Annual Meeting
|
|
Apr 25
|
Bausch + Lomb Announces 2023 Annual Meeting of Shareholder Results
|
|
Apr 24
|
Bausch + Lomb Announces U.S. Launch of StableVisc™ Cohesive Ophthalmic Viscosurgical Device and TotalVisc™ Viscoelastic System
|